Brandi Roberts - 25 Mar 2022 Form 3 Insider Report for TFF Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Brandi Roberts
Issuer symbol
N/A
Transactions as of
25 Mar 2022
Net transactions value
$0
Form type
3
Filing time
04 Apr 2022, 16:05:24 UTC
Previous filing
11 Feb 2022
Next filing
30 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TFFP Stock Option (Right to Buy) 25 Mar 2022 Common Stock 95,000 $6.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Option shall vest and first become exercisable as follows: one quarter of the Option shall vest and first become exercisable on March 2, 2023, and the remainder of the Option shall vest and first become exercisable in 12 equal quarterly installments commencing on June 2, 2023.